Hologic/HOLX

$76.15

0.35%
-
1D1W1MYTD1YMAX

About Hologic

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. It operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a wide range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. The Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD.
Ticker
HOLX
Sector
Healthcare
Trading on
NASDAQ
Industry
Medical Equipment & Supplies
CEO
Stephen Macmillan
Employees
6,990
Headquarters
Marlborough, United States

Hologic Metrics

BasicAdvanced
$17.87B
Market cap
36.20
P/E ratio
$2.10
EPS
1.01
Beta
-
Dividend rate

What the Analysts think about Hologic

Analyst Ratings

Majority rating from 18 analysts.
Buy

Price Targets

Average projection from 14 analysts.
10.97% upside
High $95.00
Low $76.00
$76.15
Current price
$84.50
Average price target

Hologic Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
24.33% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.01B
7.17%
Net income
$246.5M
172.08%
Profit margin
24.33%
153.97%

Hologic Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.03%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.06
$0.93
$0.89
$0.98
-
Expected
$0.88
$0.89
$0.84
$0.95
$0.98
Surprise
20.24%
4.43%
5.86%
3.03%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Hologic stock

Buy or sell Hologic stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing